Oui, certains antidépresseurs peuvent améliorer les symptômes liés au tRNA-Trp.
AntidépresseursTraitement médicamenteux
#3
Y a-t-il des thérapies alternatives ?
Des thérapies comme la méditation peuvent aider à gérer les symptômes.
Thérapies alternativesMéditation
#4
Le suivi médical est-il nécessaire ?
Oui, un suivi régulier est essentiel pour ajuster le traitement.
Suivi médicalAjustement thérapeutique
#5
Des changements de mode de vie sont-ils recommandés ?
Oui, une alimentation équilibrée et l'exercice régulier sont conseillés.
Mode de vie sainExercice physique
Complications
5
#1
Quelles complications peuvent survenir avec une carence en tRNA-Trp ?
Des troubles mentaux et des problèmes de croissance peuvent se développer.
ComplicationsTroubles mentaux
#2
Le tRNA-Trp est-il lié à des maladies chroniques ?
Oui, des déséquilibres peuvent contribuer à des maladies comme la dépression.
Maladies chroniquesDépression
#3
Des troubles métaboliques peuvent-ils être causés ?
Oui, une carence peut entraîner des troubles métaboliques et endocriniens.
Troubles métaboliquesEndocrinologie
#4
Y a-t-il un risque accru de maladies cardiovasculaires ?
Oui, des déséquilibres en acides aminés peuvent affecter la santé cardiaque.
Maladies cardiovasculairesAcides aminés
#5
Les complications neurologiques sont-elles possibles ?
Oui, des troubles neurologiques peuvent survenir en cas de carence prolongée.
Complications neurologiquesCarence prolongée
Facteurs de risque
5
#1
Quels sont les facteurs de risque de carence en tryptophane ?
Une alimentation déséquilibrée et des troubles digestifs augmentent le risque.
Facteurs de risqueTroubles digestifs
#2
Les personnes âgées sont-elles plus à risque ?
Oui, elles peuvent avoir des besoins nutritionnels accrus et une absorption réduite.
Personnes âgéesBesoins nutritionnels
#3
Les végétariens courent-ils un risque accru ?
Oui, ils doivent veiller à consommer suffisamment de sources de tryptophane.
VégétariensSources alimentaires
#4
Les troubles alimentaires augmentent-ils le risque ?
Oui, ils peuvent entraîner des carences en nutriments essentiels comme le tryptophane.
Troubles alimentairesCarences nutritionnelles
#5
Le stress peut-il affecter le tRNA-Trp ?
Oui, le stress chronique peut perturber le métabolisme des acides aminés.
StressMétabolisme des acides aminés
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "ARN de transfert du tryptophane : Questions médicales les plus fréquentes",
"headline": "ARN de transfert du tryptophane : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les ARN de transfert du tryptophane : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-17",
"dateModified": "2025-04-12",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "ARN de transfert du tryptophane"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "ARN de transfert spécifiques des différents acides aminés",
"url": "https://questionsmedicales.fr/mesh/D012345",
"about": {
"@type": "MedicalCondition",
"name": "ARN de transfert spécifiques des différents acides aminés",
"code": {
"@type": "MedicalCode",
"code": "D012345",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "D13.444.735.757.700"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "ARN de transfert du tryptophane",
"alternateName": "RNA, Transfer, Trp",
"code": {
"@type": "MedicalCode",
"code": "D012364",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Makoto Tominaga",
"url": "https://questionsmedicales.fr/author/Makoto%20Tominaga",
"affiliation": {
"@type": "Organization",
"name": "Division of Cell Signaling, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki, Japan; Thermal Biology Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Japan; Department of Physiological Sciences, The Graduate University for Advanced Studies (SOKENDAI), Okazaki, Japan; Institute for Environmental and Gender-Specific Medicine, Juntendo University, Chiba, Japan. Electronic address: tominaga@nips.ac.jp."
}
},
{
"@type": "Person",
"name": "Sudhanva S Kashyap",
"url": "https://questionsmedicales.fr/author/Sudhanva%20S%20Kashyap",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences, Iowa State University, Ames, IA, 50011, USA."
}
},
{
"@type": "Person",
"name": "Alan P Robertson",
"url": "https://questionsmedicales.fr/author/Alan%20P%20Robertson",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences, Iowa State University, Ames, IA, 50011, USA."
}
},
{
"@type": "Person",
"name": "Richard J Martin",
"url": "https://questionsmedicales.fr/author/Richard%20J%20Martin",
"affiliation": {
"@type": "Organization",
"name": "Department of Biomedical Sciences, Iowa State University, Ames, IA, 50011, USA. rjmartin@iastate.edu."
}
},
{
"@type": "Person",
"name": "Lixia Yue",
"url": "https://questionsmedicales.fr/author/Lixia%20Yue",
"affiliation": {
"@type": "Organization",
"name": "Department of Cell Biology, Calhoun Cardiology Center, School of Medicine (UConn Health), University of Connecticut, Farmington, CT, 06030, USA. lyue@uchc.edu."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Effect of placenta location detected by ultrasound on the severity of placenta accreta spectrum in patients with placenta previa and placenta accreta spectrum.",
"datePublished": "2023-06-01",
"url": "https://questionsmedicales.fr/article/37264325",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1186/s12884-023-05736-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Timing of cesarean delivery in women with uncomplicated placenta previa.",
"datePublished": "2022-10-19",
"url": "https://questionsmedicales.fr/article/36261133",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14767058.2022.2134772"
}
},
{
"@type": "ScholarlyArticle",
"name": "Blood Type and Outcomes in Pregnant Women with Placenta Previa.",
"datePublished": "2023-01-25",
"url": "https://questionsmedicales.fr/article/36743690",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1155/2023/4725064"
}
},
{
"@type": "ScholarlyArticle",
"name": "Effect of placenta previa on umbilical cord hematocrit value.",
"datePublished": "2022-09-29",
"url": "https://questionsmedicales.fr/article/36176062",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/14767058.2022.2128651"
}
},
{
"@type": "ScholarlyArticle",
"name": "Correlation of placental thickness and placenta percreta in patients with placenta previa: findings from MRI.",
"datePublished": "2022-09-17",
"url": "https://questionsmedicales.fr/article/36114883",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00261-022-03676-1"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Acides nucléiques, nucléotides et nucléosides",
"item": "https://questionsmedicales.fr/mesh/D009706"
},
{
"@type": "ListItem",
"position": 3,
"name": "Acides nucléiques",
"item": "https://questionsmedicales.fr/mesh/D009696"
},
{
"@type": "ListItem",
"position": 4,
"name": "ARN",
"item": "https://questionsmedicales.fr/mesh/D012313"
},
{
"@type": "ListItem",
"position": 5,
"name": "ARN de transfert",
"item": "https://questionsmedicales.fr/mesh/D012343"
},
{
"@type": "ListItem",
"position": 6,
"name": "ARN de transfert spécifiques des différents acides aminés",
"item": "https://questionsmedicales.fr/mesh/D012345"
},
{
"@type": "ListItem",
"position": 7,
"name": "ARN de transfert du tryptophane",
"item": "https://questionsmedicales.fr/mesh/D012364"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : ARN de transfert du tryptophane - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur ARN de transfert du tryptophane",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-10",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur ARN de transfert du tryptophane",
"description": "Comment diagnostiquer une anomalie du tRNA-Trp ?\nQuels tests sont utilisés pour évaluer le tRNA-Trp ?\nQuels symptômes peuvent indiquer un problème avec le tRNA-Trp ?\nLe dosage du tryptophane est-il utile ?\nPeut-on détecter des mutations dans le gène du tRNA-Trp ?",
"url": "https://questionsmedicales.fr/mesh/D012364?mesh_terms=Placenta+Previa#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur ARN de transfert du tryptophane",
"description": "Quels sont les symptômes d'une carence en tryptophane ?\nLes troubles de l'humeur sont-ils liés au tRNA-Trp ?\nY a-t-il des signes neurologiques associés ?\nComment le tRNA-Trp affecte-t-il l'appétit ?\nDes problèmes de croissance peuvent-ils survenir ?",
"url": "https://questionsmedicales.fr/mesh/D012364?mesh_terms=Placenta+Previa#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur ARN de transfert du tryptophane",
"description": "Comment prévenir une carence en tryptophane ?\nLes tests génétiques peuvent-ils aider à la prévention ?\nY a-t-il des recommandations diététiques spécifiques ?\nL'éducation nutritionnelle est-elle importante ?\nLes suppléments sont-ils nécessaires pour tout le monde ?",
"url": "https://questionsmedicales.fr/mesh/D012364?mesh_terms=Placenta+Previa#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur ARN de transfert du tryptophane",
"description": "Comment traiter une carence en tryptophane ?\nLes médicaments peuvent-ils aider ?\nY a-t-il des thérapies alternatives ?\nLe suivi médical est-il nécessaire ?\nDes changements de mode de vie sont-ils recommandés ?",
"url": "https://questionsmedicales.fr/mesh/D012364?mesh_terms=Placenta+Previa#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur ARN de transfert du tryptophane",
"description": "Quelles complications peuvent survenir avec une carence en tRNA-Trp ?\nLe tRNA-Trp est-il lié à des maladies chroniques ?\nDes troubles métaboliques peuvent-ils être causés ?\nY a-t-il un risque accru de maladies cardiovasculaires ?\nLes complications neurologiques sont-elles possibles ?",
"url": "https://questionsmedicales.fr/mesh/D012364?mesh_terms=Placenta+Previa#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur ARN de transfert du tryptophane",
"description": "Quels sont les facteurs de risque de carence en tryptophane ?\nLes personnes âgées sont-elles plus à risque ?\nLes végétariens courent-ils un risque accru ?\nLes troubles alimentaires augmentent-ils le risque ?\nLe stress peut-il affecter le tRNA-Trp ?",
"url": "https://questionsmedicales.fr/mesh/D012364?mesh_terms=Placenta+Previa#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une anomalie du tRNA-Trp ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests génétiques et des analyses biochimiques peuvent être effectués."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour évaluer le tRNA-Trp ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'électrophorèse et la spectrométrie de masse sont couramment utilisés."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer un problème avec le tRNA-Trp ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles neurologiques et des retards de développement peuvent survenir."
}
},
{
"@type": "Question",
"name": "Le dosage du tryptophane est-il utile ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il peut aider à évaluer la fonction du tRNA-Trp dans l'organisme."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des mutations dans le gène du tRNA-Trp ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des techniques de séquençage peuvent identifier des mutations spécifiques."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes d'une carence en tryptophane ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fatigue, dépression et troubles du sommeil peuvent se manifester."
}
},
{
"@type": "Question",
"name": "Les troubles de l'humeur sont-ils liés au tRNA-Trp ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une dysfonction du tRNA-Trp peut affecter la synthèse de neurotransmetteurs."
}
},
{
"@type": "Question",
"name": "Y a-t-il des signes neurologiques associés ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des convulsions et des troubles cognitifs peuvent être observés."
}
},
{
"@type": "Question",
"name": "Comment le tRNA-Trp affecte-t-il l'appétit ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il joue un rôle dans la régulation de la sérotonine, influençant l'appétit."
}
},
{
"@type": "Question",
"name": "Des problèmes de croissance peuvent-ils survenir ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence en tryptophane peut entraîner un retard de croissance."
}
},
{
"@type": "Question",
"name": "Comment prévenir une carence en tryptophane ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation riche en protéines et en acides aminés essentiels est clé."
}
},
{
"@type": "Question",
"name": "Les tests génétiques peuvent-ils aider à la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent identifier les personnes à risque de troubles liés au tRNA-Trp."
}
},
{
"@type": "Question",
"name": "Y a-t-il des recommandations diététiques spécifiques ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Consommer des aliments riches en tryptophane comme les noix et les produits laitiers."
}
},
{
"@type": "Question",
"name": "L'éducation nutritionnelle est-elle importante ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle aide à comprendre l'importance des acides aminés dans l'alimentation."
}
},
{
"@type": "Question",
"name": "Les suppléments sont-ils nécessaires pour tout le monde ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont nécessaires que pour ceux qui ont des besoins accrus."
}
},
{
"@type": "Question",
"name": "Comment traiter une carence en tryptophane ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des suppléments de tryptophane et des modifications alimentaires sont recommandés."
}
},
{
"@type": "Question",
"name": "Les médicaments peuvent-ils aider ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains antidépresseurs peuvent améliorer les symptômes liés au tRNA-Trp."
}
},
{
"@type": "Question",
"name": "Y a-t-il des thérapies alternatives ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des thérapies comme la méditation peuvent aider à gérer les symptômes."
}
},
{
"@type": "Question",
"name": "Le suivi médical est-il nécessaire ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi régulier est essentiel pour ajuster le traitement."
}
},
{
"@type": "Question",
"name": "Des changements de mode de vie sont-ils recommandés ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation équilibrée et l'exercice régulier sont conseillés."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec une carence en tRNA-Trp ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des troubles mentaux et des problèmes de croissance peuvent se développer."
}
},
{
"@type": "Question",
"name": "Le tRNA-Trp est-il lié à des maladies chroniques ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres peuvent contribuer à des maladies comme la dépression."
}
},
{
"@type": "Question",
"name": "Des troubles métaboliques peuvent-ils être causés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une carence peut entraîner des troubles métaboliques et endocriniens."
}
},
{
"@type": "Question",
"name": "Y a-t-il un risque accru de maladies cardiovasculaires ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des déséquilibres en acides aminés peuvent affecter la santé cardiaque."
}
},
{
"@type": "Question",
"name": "Les complications neurologiques sont-elles possibles ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des troubles neurologiques peuvent survenir en cas de carence prolongée."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque de carence en tryptophane ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation déséquilibrée et des troubles digestifs augmentent le risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus à risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elles peuvent avoir des besoins nutritionnels accrus et une absorption réduite."
}
},
{
"@type": "Question",
"name": "Les végétariens courent-ils un risque accru ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils doivent veiller à consommer suffisamment de sources de tryptophane."
}
},
{
"@type": "Question",
"name": "Les troubles alimentaires augmentent-ils le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, ils peuvent entraîner des carences en nutriments essentiels comme le tryptophane."
}
},
{
"@type": "Question",
"name": "Le stress peut-il affecter le tRNA-Trp ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut perturber le métabolisme des acides aminés."
}
}
]
}
]
}
Division of Cell Signaling, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki, Japan; Thermal Biology Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Japan; Department of Physiological Sciences, The Graduate University for Advanced Studies (SOKENDAI), Okazaki, Japan; Institute for Environmental and Gender-Specific Medicine, Juntendo University, Chiba, Japan. Electronic address: tominaga@nips.ac.jp.
Publications dans "ARN de transfert du tryptophane" :
Department of Cell Biology, Calhoun Cardiology Center, School of Medicine (UConn Health), University of Connecticut, Farmington, CT, 06030, USA. lyue@uchc.edu.
Publications dans "ARN de transfert du tryptophane" :
Division of Cell Signaling, National Institute for Physiological Sciences, National Institutes of Natural Sciences, Okazaki, Japan; Thermal Biology Group, Exploratory Research Center on Life and Living Systems (ExCELLS), National Institutes of Natural Sciences, Okazaki, Japan; Department of Physiological Sciences, The Graduate University for Advanced Studies (SOKENDAI), Okazaki, Japan. Electronic address: mkashio@nips.ac.jp.
Publications dans "ARN de transfert du tryptophane" :
Department of Cell Biology, Calhoun Cardiology Center, School of Medicine (UConn Health), University of Connecticut, Farmington, CT, 06030, USA. zong@uchc.edu.
Institute for the Brain and Cognitive Sciences, University of Connecticut, 337 Mansfield Road, Unit 1272, Storrs, CT, 06269, USA. zong@uchc.edu.
Publications dans "ARN de transfert du tryptophane" :
Department of Systems Pharmacology and Translational Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA. Electronic address: vmb@pennmedicine.upenn.edu.
Publications dans "ARN de transfert du tryptophane" :
Ministry of Education Key Laboratory of Molecular Microbiology and Technology, Department of Microbiology, College of Life Science, Nankai University, Tianjin 300071, China.
Publications dans "ARN de transfert du tryptophane" :
Ministry of Education Key Laboratory of Molecular Microbiology and Technology, Department of Microbiology, College of Life Science, Nankai University, Tianjin 300071, China.
Publications dans "ARN de transfert du tryptophane" :
Ministry of Education Key Laboratory of Molecular Microbiology and Technology, Department of Microbiology, College of Life Science, Nankai University, Tianjin 300071, China.
Publications dans "ARN de transfert du tryptophane" :
Ministry of Education Key Laboratory of Molecular Microbiology and Technology, Department of Microbiology, College of Life Science, Nankai University, Tianjin 300071, China.
Publications dans "ARN de transfert du tryptophane" :
To evaluate the effect of placental location on the severity of placenta accreta spectrum (PAS)....
We analyzed 390 patients with placenta previa combined with placenta accreta spectrum who underwent cesarean section between January 1, 2014 and December 30, 2020 in the electronic case database of th...
The history of cesarean delivery rates in the anterior group (91.67%) and the non-central group (85.71%) were statistically different from the posterior group (63.74%)(P < 0.001). Univariate logistic ...
Compared with posterior placenta, anterior and non-central placenta are independent risk factors for invasive PAS in patients with placenta previa, during which we should be more cautious in treatment...
The optimal timing of an elective cesarean delivery for uncomplicated placenta previa remains controversial. Although the present guidelines recommend an elective cesarean delivery between 36...
A retrospective cohort study in a single tertiary medical center of 251 women with a diagnosis of uncomplicated placenta previa, who delivered between 36...
At 36...
Our study suggests that the optimal time of delivery for women with an uncomplicated placenta previa is between 38...
Placenta previa increases the risks of obstetrical complications. Many studies have reported a link between various ABO blood types and pregnancy complications. This study is aimed at describing and c...
Data for this study was obtained from a retrospective cohort study between January 1, 2014, and June 30, 2019, of all clinically confirmed placenta previa in a university-based tertiary medical center...
1678 participants with placenta previa were included in this study. The highest participants were blood type O with 666 (39.7%), followed by type A with 508 (30.3%) and type B with 395 (23.5%), and th...
Type AB blood may be a potential risk factor for women with placenta previa. This finding may help provide any obstetrician to predict the risk of complication for placenta previa women by the ABO blo...
Placenta previa is one of the causes of neonatal anemia. This condition is mainly explained by antenatal hemorrhage and incision of the anteriorly located placenta during cesarean section. However, th...
This prospective study investigated 47 patients with previa and 43 control patients who gave birth with a cesarean section at 34-38 weeks of gestation. Blood samples were obtained from the fetal end o...
The study findings reveal that even if not complicated by antepartum or intrapartum hemorrhage, placenta previa may be associated with lower hematocrit values in newborns. Although in none of the case...
This study aimed to identify if placental thickness measured from MRI images correlated with placenta percreta in patients with placenta previa....
Placental thickness was retrospectively measured in 161 patients from July 2018 to August 2020. The measurements were performed at the thickest part of the placenta in the lower uterine segment on the...
Placental thickness in patients with placenta percreta was significantly higher than in patients with placenta increta, placenta accreta, and normal placentas (p < 0.05). Multivariate analysis reveale...
Patients with placenta percreta had the highest placental thickness. Placental thickness was correlated with placenta percreta....
This systematic review and meta-analysis aimed to assess clinical characteristics related to pathologically proven placenta accreta spectrum without placenta previa....
A literature search of PubMed, the Cochrane database, and Web of Science was performed from inception to September 7, 2022....
The primary outcomes were invasive placenta (including increta or percreta), blood loss, hysterectomy, and antenatal diagnosis. In addition, maternal age, assisted reproductive technology, previous ce...
Study screening was conducted after duplicates were identified and removed. The quality of each study and the publication bias were assessed. Forest plots and I...
Among 2598 studies that were initially retrieved, 5 were included in the review. With the exception of 1 study, 4 studies were included in the meta-analysis. This meta-analysis showed that placenta ac...
The differences in clinical aspects of placenta accreta spectrum with and without placenta previa need to be understood....
Placental accreta spectrum (PAS) disorder with bladder involvement can be associated with maternal and neonatal morbidity. Magnetic resonance imaging (MRI) may provide accurate preoperative diagnoses....
This study had 2 aims: to retrospectively review the MRI findings for bladder involvement in PAS with placental previa and to correlate bladder involvement with maternal and neonatal outcomes....
MRI images of 48 patients with severe PAS (increta and percreta) with placenta previa/low-lying placenta were evaluated by 2 experienced radiologists blinded to the final diagnoses. Nine MRI findings ...
Of the 48 patients, 27 did not have bladder involvement, while 21 did. Logistic regression analysis identified 2 predictive MRI features for bladder involvement. They were abnormal vascularization (OR...
PAS with bladder involvement was significantly correlated with massive surgical blood loss. Prenatally, the disorder was predicted with high specificity by the combination of loss of chemical shift ar...
To determine the rate of resolution of placenta previa and low-lying placenta (LLP) and the effect of pelvic rest recommendations on the timing of follow-up imaging....
Retrospective review of pregnancies with previa/LLP detected on mid-trimester exam at our ultrasound unit from 2019 to 2021. LLP was defined as the lower edge of placenta located within 2 cm of the in...
Exactly 144 patients had previa and 266 had LLP on the mid-trimester exam with complete records. Previa resolution happened in 51.4% (74/144) of cases. Exactly 62% (46/74) of previa resolutions occurr...
Most societies recommend follow-up imaging at 32 weeks; however, our results suggest this may be done sooner and closer to 28 weeks. Pelvic rest did not affect timing of repeat imaging or delivery....
To determine whether women who experience resolution of low placentation (low-lying placenta or placenta previa) are at increased risk of postpartum hemorrhage compared to those with normal placentati...
This was a retrospective cohort study of women who delivered at Mount Sinai Hospital between 2015 and 2019, and who were diagnosed with low-lying placenta or placenta previa on transvaginal ultrasound...
A total of 1256 women were identified for analysis, of whom 628 had resolved low placentation and 628 had normal placentation. Women with resolved low placentation, compared to those with normal place...
Despite high rates of resolution of low-lying placenta and placenta previa by term, women with resolved low placentation remain at increased risk of postpartum hemorrhage compared to those with normal...
Placenta previa is widely acknowledged as a risk factor for placenta accreta spectrum (PAS) disorders, which are severe maternal complications; however, data are limited regarding whether placenta pre...
To examine the association between placenta previa and the risk of severe maternal morbidities (SMMs) and higher resource use among patients with PAS disorders....
This retrospective cohort study extracted records of 3793 patients with PAS diagnosis and delivery indicators between October 1, 2015, and December 31, 2019, from the US National Inpatient Sample data...
Placenta previa....
Data on 21 Centers for Disease Control and Prevention-defined SMMs and 25 study-defined surgical morbidities associated with PAS were extracted. Six surgical procedures (cystoscopy, intra-arterial bal...
Among 3793 patients with PAS (median [IQR] age at admission, 33 [29-37] years), 621 women (16.4%) were Black, 765 (20.2%) were Hispanic, 1779 (46.9%) were White, 441 (11.6%) were of other races and/or...
In this study, placenta previa was associated with an increased risk of maternal and surgical morbidities and higher resource use among women with PAS. These findings suggest that interventions to all...
